胆胰支长度可能是2型糖尿病患者Roux-en-Y胃旁路术后血糖结局更优的关键因素:一项Meta分析
该Meta分析纳入28篇文章,按胆胰支和Roux支长度分四组,比较Roux-en-Y胃旁路术后2型糖尿病缓解与改善率。长胆胰支-长Roux支组缓解率0.80、改善率0.81,长胆胰支-短Roux支组分别为0.76和0.82,短胆胰支-长Roux支组为0.57和0.64,短胆胰支-短Roux支组为0.62和0.53。Meta回归显示胆胰支更长与更高的缓解和改善率相关,而Roux支更长无此关联。
要点
- 长胆胰支-长Roux支组糖尿病缓解率0.80(95%CI 0.70-0.90),改善率0.81(0.73-0.89)。
- 长胆胰支-短Roux支组缓解率0.76(0.66-0.87),改善率0.82(0.75-0.89)。
- 短胆胰支-长Roux支组缓解率0.57(0.36-0.78),改善率0.64(0.53-0.75)。
核心结论
- 与Roux支更长相比,胆胰支更长使Roux-en-Y胃旁路术后1年时2型糖尿病缓解率和改善率更高。
研究设计与样本
- 系统检索PubMed、Embase和Cochrane Library数据库,纳入报告Roux-en-Y胃旁路术后血糖结局及胆胰支和Roux支长度的研究。
- 共纳入28篇文章进行数据提取,按胆胰支和Roux支长度将研究分为四组。
- 血糖结局基于缓解和改善两种定义评估。
主要发现
- 长胆胰支-长Roux支组缓解率0.80(95%CI 0.70-0.90),改善率0.81(0.73-0.89)。
- 长胆胰支-短Roux支组缓解率0.76(0.66-0.87),改善率0.82(0.75-0.89)。
- 短胆胰支-长Roux支组缓解率0.57(0.36-0.78),改善率0.64(0.53-0.75)。
- 短胆胰支-短Roux支组缓解率0.62(0.43-0.80),改善率0.53(0.45-0.61)。
- Meta回归分析显示胆胰支更长与更高的术后2型糖尿病缓解率和改善率相关,而Roux支更长无此关联;四组间基线特征(包括糖尿病相关变量)无显著差异或异质性。
局限性
- 并非所有纳入研究均为随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimal length of biliopancreatic (BP) and Roux limb in Roux-en-Y gastric bypass (RYGB) for improved glycemic control are not known. PURPOSE: To investigate how the lengths of the BP and Roux limbs in RYGB differentially affect postoperative glycemic outcomes in patients with type 2 diabetes. DATA SOURCES: We conducted a systematic literature search using the PubMed, Embase, and the Cochrane Library databases. STUDY SELECTION: We included studies that reported glycemic outcomes after RYGB and lengths of the BP and Roux limbs. DATA EXTRACTION: A total of 28 articles were included for data extraction. Glycemic outcomes after RYGB were assessed on the basis of two definitions: remission and improvement. DATA SYNTHESIS: We categorized the included studies into four groups according to the BP and Roux limb lengths. The type 2 diabetes remission/improvement rates were as follows: long BP-long Roux group 0.80 (95% CI 0.70-0.90)/0.81 (0.73-0.89), long BP-short Roux group 0.76 (0.66-0.87)/0.82 (0.75-0.89), short BP-long Roux group 0.57 (0.36-0.78)/0.64 (0.53-0.75), and short BP-short Roux group 0.62 (0.43-0.80)/0.53 (0.45-0.61). Meta-regression analysis also showed that a longer BP limb resulted in higher postoperative type 2 diabetes remission and improvement rates, whereas a longer Roux limb did not. There was no significant difference or heterogeneity in baseline characteristics, including diabetes-related variables, among the four groups. LIMITATIONS: Not all included studies were randomized controlled trials. CONCLUSIONS: Longer BP limb length led to higher rates of type 2 diabetes remission and improvement by 1 year after RYGB in comparisons with the longer Roux limb length.
引用
- Kwon Y, Lee S, Kim D, et al. Biliopancreatic Limb Length as a Potential Key Factor in Superior Glycemic Outcomes After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes: A Meta-Analysis. Diabetes Care. 2022. PMID: 36455123. doi:10.2337/dc22-0835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。